Eli Lilly is making a play for the idiopathic pulmonary fibrosis (IPF) market, offering Mediar Therapeutics $99 million in upfront and near-term payments for global rights to an asset that is ...

Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan Healthcare Conference with a deal to buy Scorpion Therapeutics ...

On board the plane was 60 passengers and four crew members. Wichita Mayor Lily Wu called Wednesday's crash a "terrible tragedy" and said it "will unite those in Washington, D.C., and Kansas ...

For nearly a decade, Eli Lilly has been operating a global capability center (GCC) in Bengaluru, India. Now, with its business booming, the company is setting up a similar site 10 hours to the ...

SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion, as the Indianapolis company broadens its pipeline.

Two 12-year-old figure skaters, several foreign nationals, two military personnel, a pair of world champion skaters from Russia, a police official from the Philippines, several members of the ...

Eli Lilly & Co.’s fourth-quarter revenue fell short of analysts’ estimates as the drugmaker struggled to forecast demand for its popular weight-loss and diabetes shots for the second quarter ...

Global pharma major Eli Lilly and Company is setting up a new global capability centre in Hyderabad, a facility for which more than 1,000 people are to be recruited. The Lilly Capability Centre ...

Shares of Eli Lilly have been falling in recent months, but that could spell opportunity. Investors appear to be concerned that a new government could impact its growth potential. The business is ...